Why Does Melatonin Have a Bad Reputation?

Melatonin use in the US more than quintupled between 1999 and 2018 — yet the supplement's reputation has soured for many users. Grogginess the next morning, disappointing results, and questions about dependency have left millions wondering whether melatonin is actually safe. This guide separates the myths from the real problems, and shows what the science says about using melatonin correctly.

Table of Contents

1. What Melatonin Actually Does
2. The Dose Problem: Why Most People Take Too Much
3. Mislabeled Products: The Hidden Source of Bad Experiences
4. Grogginess Explained: Real Problem, Avoidable Cause
5. The Dependency Myth: What Research Actually Shows
6. The Absorption Advantage: Getting More from Less
7. BioAbsorb Liposomal Melatonin: A Smarter Approach
8. Frequently Asked Questions
9. Conclusion

1. What Melatonin Actually Does

Melatonin is a hormone your brain's pineal gland releases in response to darkness. It doesn't knock you out like a sedative — it signals to your body that night has arrived, nudging your circadian rhythm toward sleep. Your pineal gland naturally produces between 0.1 mg and 0.9 mg per night — a remarkably small amount that is nonetheless sufficient to orchestrate your entire sleep-wake cycle.

This distinction — circadian signal vs. sedative — is critical to understanding why melatonin's reputation suffers. When people expect it to work like a sleeping pill, they take large doses at the wrong time and measure success by how fast they fall asleep, rather than by whether their internal clock has shifted. According to the NIH's NCCIH, evidence supports melatonin for jet lag, delayed sleep-wake phase disorder, and specific circadian conditions — but evidence for treating general insomnia is inconsistent.

The gap between what melatonin can do and what consumers expect it to do is where much of its bad reputation originates. A supplement that reduces sleep onset by a mean of 7 minutes across 1,683 subjects is a real, clinically meaningful effect — but it will disappoint anyone expecting to be asleep within 10 minutes of a 10 mg gummy. Setting the right expectations is the first step to using melatonin well.

2. The Dose Problem: Why Most People Take Too Much

Walk into any pharmacy and you'll find melatonin products ranging from 1 mg to 20 mg per serving. This range exists because melatonin is classified as a dietary supplement in the United States, meaning the FDA does not establish or enforce dosage ceilings the way it would for a prescription drug. The result is a marketplace where 5 mg and 10 mg products dominate shelf space — doses 10 to 100 times higher than what the body produces naturally each night.

Research consistently points to a lower target. Sleep medicine specialists recommend starting with 0.5 to 1 mg and rarely exceeding 5 mg. A Cochrane review confirmed that melatonin doses above 5 mg used for jet lag provided no additional benefit over lower doses. Yet because "more is better" logic governs how most people approach supplements, the typical consumer reaches for a 5 mg or 10 mg pill and wonders why they feel foggy the next morning.

• Body's natural nightly production: 0.1–0.9 mg
• Expert-recommended starting dose: 0.5–1 mg
• Most common OTC dose: 5–10 mg
• Cochrane review finding: doses above 5 mg add no extra benefit for jet lag

For people who want precise control over their dose, a liquid format with a graduated dropper — like BioAbsorb's liposomal melatonin, which delivers 1.5 mg per full dropper in approximately 0.25 mg increments — makes it genuinely easy to titrate down from the tablet-sized doses most people start with.

3. Mislabeled Products: The Hidden Source of Bad Experiences

Here is a fact that receives far too little attention in melatonin discussions: a significant portion of the "bad experiences" people attribute to melatonin are actually bad experiences with the wrong dose of melatonin — caused by inaccurate product labeling. A landmark 2023 study published in JAMA analyzed 25 gummy melatonin products and found that 22 of them (88%) contained the wrong amount. Actual melatonin content ranged from 74% to 347% of what was stated on the label. One product contained no melatonin at all.

This is not a new problem. A 2017 Canadian study found that actual melatonin content in products varied from 83% to 478% of the labeled amount, with 26% of samples containing serotonin as a contaminant. A consumer who buys a "3 mg" gummy and receives 10 mg is not experiencing a reaction to melatonin — they are experiencing an unintended overdose. Their subsequent conviction that "melatonin doesn't work for me" or "melatonin makes me feel terrible" may be entirely correct — about that product — but incorrect about melatonin as a supplement.

The practical implication is straightforward: third-party tested products with batch-level certificates of analysis are materially safer than products with no independent verification. BioAbsorb's melatonin is third-party tested per batch, with a COA available on request — the kind of quality assurance that eliminates the labeling lottery that plagues the broader supplement market.

4. Grogginess Explained: Real Problem, Avoidable Cause

Morning grogginess — sometimes called the "melatonin hangover" — is one of the most frequently cited reasons people stop using melatonin. It is also one of the most preventable. A systematic review of 37 randomized controlled trials found daytime sleepiness occurring in only 1.66% of participants at therapeutic doses. The problem is that most consumers are not taking therapeutic doses — they are taking doses 5–20 times higher than what the research recommends.

The mechanism is straightforward. Melatonin has an elimination half-life of roughly 40–60 minutes. At physiological doses (0.3–1 mg), most of the supplement has cleared your system within 4–6 hours. At 10 mg, residual melatonin remains active well into the morning — especially for older adults, who metabolize melatonin more slowly. Taking melatonin too late at night compounds the problem: a 10 mg dose at midnight means peak melatonin activity may extend to 5 or 6 AM, exactly when you need to wake up.

The fix is usually simple: lower the dose, take it earlier (30–60 minutes before your target bedtime rather than right at lights-out), and switch to an immediate-release format rather than extended-release. At a dose of 1.5 mg with 15–30 minute onset via liposomal delivery, the active window aligns cleanly with a natural sleep cycle — leaving no morning overhang.

5. The Dependency Myth: What Research Actually Shows

One of melatonin's most persistent reputation problems is the fear that regular use will suppress your body's own melatonin production, create dependency, or require increasingly higher doses over time. This concern is understandable — it is how many other sleep medications work. But the evidence for melatonin specifically does not support it. The 2013 PLOS ONE meta-analysis of 1,683 subjects concluded explicitly that melatonin "has little dependence potential, is not associated with habituation, and typically produces no hangover."

Physical addiction requires three hallmarks: withdrawal symptoms, tolerance build-up requiring higher doses over time, and compulsive use despite harm. Cleveland Clinic sleep specialists confirm that none of these apply to melatonin. There is no documented withdrawal syndrome, no established tolerance mechanism, and no evidence that the brain reduces endogenous melatonin production in response to exogenous supplementation. What does occur — and is worth acknowledging honestly — is that some people develop a psychological reliance, feeling unable to sleep without the supplement. This is a habit, not a physiological dependency, and it responds well to gradual tapering.

Long-term safety data remain limited, and ongoing research is appropriate. But the common assertion that "melatonin is addictive" or that "your brain will stop making its own" is not supported by current evidence. The fear appears to have transferred from concerns about benzodiazepines and other sedative-hypnotics onto a fundamentally different class of compound — a naturally occurring hormone with a benign side-effect profile at appropriate doses.

6. The Absorption Advantage: Getting More from Less

Even if you solve the dosing problem and choose a third-party tested product, there remains a fundamental pharmacokinetic challenge with standard oral melatonin tablets: most of what you swallow never reaches your bloodstream. A pharmacokinetics study published in the Journal of Clinical Pharmacology established the absolute bioavailability of oral melatonin tablets at approximately 15%, with considerable variation between individuals. Up to 85% of each dose is metabolized by the liver before it can circulate — a process called first-pass metabolism.

This creates an ironic situation: the oversized doses that cause grogginess and side effects exist partly because manufacturers are compensating for poor absorption. Take a 10 mg tablet expecting 10 mg of effect, and you actually get roughly 1.5 mg of active melatonin — but with the liver also processing 8.5 mg and generating metabolic byproducts that can disrupt sleep architecture. The higher the dose, the more the liver must process, and the greater the unpredictability in how much actually reaches the brain.

Liposomal delivery bypasses first-pass metabolism by encapsulating melatonin in lipid spheres that absorb through mucosal tissue before reaching the liver. This is not a marketing claim — it is established pharmaceutical science used across drug delivery research. The result is faster onset (15–30 minutes vs. 60–90 minutes for tablets) and higher effective delivery, which means a physiologically appropriate 1.5 mg dose can deliver a comparable — or superior — sleep signal to a 5 mg tablet at a fraction of the liver burden.

7. BioAbsorb Liposomal Melatonin: A Smarter Approach

BioAbsorb Nutraceuticals developed their liposomal melatonin specifically to address the two root causes behind melatonin's bad reputation: inaccurate dosing and poor absorption. The result is a product that works with the science rather than against it.

The formulation delivers 1.5 mg per full dropper (1 ml), with a graduated dropper that allows adjustments in approximately 0.25 mg increments — so you can start at 0.5 mg or 0.75 mg and find your personal threshold rather than accepting whatever dose a tablet manufacturer decided to stamp out at scale. Bioavailability is 80–95%, compared to the 15–20% typical of standard tablets. Onset is 15–30 minutes, compared to the 60–90 minutes of a tablet that must survive the digestive tract before any absorption begins.

For quality assurance, every batch is third-party tested and a Certificate of Analysis is available on request — addressing the labeling-accuracy problem the 2023 JAMA study exposed across the broader market. The product is manufactured in a GMP-certified, Health Canada–approved facility in Canada, is non-GMO, vegan, and gluten-free, with no artificial flavours or colours. At $29.99 for 100 ml (100 servings), a single serving costs $0.30 — considerably less per dose than most high-dose gummies, and with far more control over what you are actually taking.

If you have had bad experiences with melatonin in the past — grogginess, inconsistent results, or the sense that it just "didn't work" — the most likely culprits are the problems described in this article: too high a dose, inaccurate labeling, poor absorption, or wrong timing. A 0.5–1 mg dose of a verified, high-bioavailability product taken 30–60 minutes before bed is a materially different experience than a 10 mg gummy taken right at lights-out.

Frequently Asked Questions

Does melatonin cause dependency or addiction?

No. Research across 1,683 subjects and multiple expert bodies including the Cleveland Clinic confirm that melatonin does not cause physical dependence, withdrawal symptoms, or tolerance build-up. Some users develop a psychological habit of relying on it, but this is distinct from physiological addiction and can be addressed by gradually reducing the dose over time.

Why does melatonin make me groggy the next morning?

Almost always, next-morning grogginess traces back to too high a dose or taking it too late. Clinical trial data show daytime sleepiness in only 1.66% of subjects at therapeutic doses (0.5–3 mg). At 10 mg taken close to bedtime, residual melatonin can remain active into morning. Try dropping to 1–2 mg and taking it 45–60 minutes before your target sleep time.

Are melatonin supplements accurately labeled?

Frequently not. A 2023 JAMA study found 88% of gummy melatonin products contained the wrong dose — some had 347% of the labeled amount. Choose products that are third-party tested with a batch-level Certificate of Analysis to avoid taking an unintended overdose.

Is melatonin effective, or is it just a placebo?

It is genuinely effective for specific uses. A meta-analysis of 19 randomized controlled trials found melatonin reduced sleep onset latency by a mean of 7 minutes and increased total sleep time by 8 minutes versus placebo — statistically significant and clinically real. It works best for circadian rhythm disruptions like jet lag and delayed sleep phase, not as a general sedative.

Why does melatonin sometimes not work at all?

Two likely reasons: timing and absorption. Melatonin works as a circadian signal, not a sedative, so taking it too close to an already-delayed bedtime provides little benefit. And with standard tablets absorbing at only approximately 15%, the effective dose from a 5 mg tablet may be under 1 mg. Try taking it 1–2 hours before your target sleep time at a consistent hour each night.

Is melatonin safe for long-term use?

Short-term use is well-established as safe for most healthy adults. Long-term data are more limited — as the NIH notes, most studies run 4 weeks or less. This does not mean long-term use is unsafe; it means the evidence base is thinner. If you are using melatonin nightly for sleep, it is worth discussing with a healthcare provider, particularly to ensure you are addressing any underlying sleep hygiene issues rather than relying solely on supplementation.

Conclusion

Melatonin's bad reputation is largely a product of the supplement market's failure to follow the science: products containing 5–10 mg when 0.5 mg may be sufficient, 88% of gummies labeled inaccurately, and standard tablets delivering only 15% of the dose to your bloodstream. The hormone itself — when taken at the right dose, at the right time, from a verified and accurately labeled product — has a genuinely benign safety profile and real clinical benefit for circadian rhythm disruption. If melatonin has let you down before, the problem is almost certainly not the hormone. It is how it was delivered.

Research References

1. Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review. CNS Drugs, Vol. 33 (2019). Systematic review of 37 RCTs finding daytime sleepiness occurred in 1.66% of subjects; most adverse events were minor and self-resolving. Supports claims about melatonin's side-effect profile at therapeutic doses. PMID: 31722088.
2. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US. JAMA, Vol. 329, No. 16 (2023). Laboratory analysis of 25 gummy products finding 88% were inaccurately labeled, with melatonin content ranging from 74% to 347% of declared quantity. Supports the mislabeling section.
3. Trends in Use of Melatonin Supplements Among US Adults, 1999–2018. JAMA, Vol. 327, No. 5 (2022). NHANES-based study of 55,021 adults documenting a fivefold increase in melatonin use; rising use of doses above 5 mg/day noted as a safety concern. PMID: 35103775.
4. Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders. PLOS ONE, Vol. 8, No. 5 (2013). Meta-analysis of 19 RCTs (1,683 subjects) finding melatonin reduces sleep onset by 7 minutes and increases total sleep time by 8 minutes; notes melatonin has little dependence potential and is not associated with habituation.
5. The Absolute Bioavailability of Oral Melatonin. Journal of Clinical Pharmacology, Vol. 40 (2000). Pharmacokinetics study in 12 healthy volunteers establishing ~15% absolute bioavailability for oral tablets due to first-pass hepatic metabolism. Supports the absorption section. PMID: 10883420.
6. Melatonin: What You Need to Know. National Institutes of Health — National Center for Complementary and Integrative Health (NCCIH, 2023). Overview of evidence base for melatonin; confirms strong evidence for jet lag and DSWPD, inconsistent evidence for general insomnia, and notes lack of FDA dosage regulation.
7. Melatonin Dosage: How Much Should You Take? Sleep Foundation (2024). Reviews research showing the body produces 0.1–0.9 mg nightly and ideal supplemental doses are 0.3–0.5 mg; notes most OTC products substantially exceed this range.
8. Chronic Administration of Melatonin: Physiological and Clinical Considerations. Nutrients, Vol. 15 (2023). Review documenting melatonin content variability from 83% to 478% of labeled amounts in commercial products, and serotonin contamination in 26% of samples.
9. The Truth About Melatonin Addiction. Cleveland Clinic (2022). Medically reviewed clinical overview confirming absence of physical dependency, tolerance, or withdrawal with melatonin; distinguishes psychological habit from physiological dependence.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.